Endogenous nonapeptide hormone

Oxytocin

A nine-amino-acid neuropeptide and hormone studied across obstetrics, social neuroscience, pain modulation, and autonomic research.

Also referred to as: OXT, OT, alpha-hypophamine
Research use only. This page summarizes published scientific literature. It is not medical advice, not a recommendation, and not a claim that this compound treats, cures or prevents any condition. Nothing here is a suggestion to use it.

What Oxytocin is

Oxytocin is an endogenous nonapeptide synthesized in the hypothalamus and released by the posterior pituitary. It is among the most thoroughly characterized peptides in human medicine because of long-standing obstetric uses, while a parallel research literature explores social cognition, stress responsivity, metabolic signals, and pain processing. Pharmacologically, oxytocin is notable for a very short plasma half-life after intravenous dosing, which is why obstetric protocols often rely on controlled infusions. Research outside obstetrics frequently uses intranasal delivery when central nervous system questions are in view; subcutaneous routes appear in selected experimental pain and animal studies. A 2024 randomized trial reported that a low microgram-range subcutaneous dose modulated heat-pain ratings in healthy adults, adding a peer-reviewed SC data point. Educational dosage content must separate approved obstetric regimens, intranasal social-neuroscience doses (often 24 IU in experimental paradigms), and research-peptide vial math. This page is research-and-education oriented with research-use-only framing for non-labeled contexts, not a guide for unsupervised hormone use.

Oxytocin has been studied in human trials, which is not true of most compounds in this library. The figures below come from that work.

How it works

Oxytocin binds the G protein-coupled oxytocin receptor (OXTR), expressed in uterus, mammary tissue, brain circuits, and peripheral sites. Receptor activation engages phospholipase C and calcium-dependent pathways that drive uterine smooth-muscle contraction and milk ejection in physiologic contexts. Centrally, OXTR signaling modulates social salience, anxiety-related circuits, and autonomic tone in experimental paradigms. Peripheral analgesic effects discussed in recent SC research may involve local receptor mechanisms in addition to any central actions.

Who works with it, and what they are measuring

Obstetric clinical pharmacologists, affective and social neuroscientists, pain researchers, and endocrinology labs mapping OXTR distribution all work with oxytocin. Behavioral science groups dominate the intranasal literature. Peptide-education audiences often arrive via research-vial contexts and need help distinguishing IU obstetric dosing from mcg research vials.

What the research examines

obstetric pharmacologysocial neurosciencestress and affiliation biologyexperimental pain modulationmetabolic and autonomic research

Research areas, not results. A topic on this list is being studied, not settled.

How it appears in the literature

Taken from the methods sections of the cited work. Not a recommendation.

Research contextReported amountFrequencyRoute
Experimental subcutaneous research (example peer-reviewed human SC study)4 mcgsingle-dose experimentalsubcutaneous
Common intranasal experimental neuroscience paradigmsNot a fixed mcg valuestudy-defined (often single or limited repeated sessions)intranasal
Secondary research-peptide discussions of SC ranges (less standardized than obstetric IV/IM labeling)10 mcg – 100 mcgvaries widely in informal sourcessubcutaneous
See the full Oxytocin dosage chart, reconstitution math and calculator →

Handling & storage

Protect from heat and light; refrigerated storage is standard for oxytocin preparations. Reconstituted research solutions should be kept cold, tightly capped, and discarded per stability guidance. Oxytocin is oxidation- and temperature-sensitive relative to hardier lyophilized research peptides.

Notes on combined research

Neuroscience studies typically administer oxytocin alone when measuring social or stress endpoints. Combining with other neuropeptides confounds interpretation of OXTR-specific effects. Obstetric clinical protocols likewise do not stack research peptides; they follow labeled labor or postpartum pathways under medical supervision.

Oxytocin questions

It depends entirely on context. Obstetric labeling uses IU for IV infusion or IM injection under clinical care. Social neuroscience often studies about 24 IU intranasally. A 2024 pain trial used 4 mcg subcutaneously as a single experimental dose. Research-vial mcg charts are not interchangeable with labor-and-delivery orders.

For a 10 mg research vial, even 2-3 mL produces a very concentrated solution relative to low-mcg experimental targets, so serial dilution may be required for accurate microgram dosing. Document every dilution step. Clinical products arrive with their own diluents and concentrations.

There is no general per-day research standard analogous to once-weekly incretins. Obstetric use is continuous or event-driven. Behavioral studies are usually session-based. Chronic daily SC schedules online should be treated skeptically without primary support.

Separate charts by route: IU for labeled obstetric products, IU for intranasal experimental sprays, and mcg for reconstituted research vials. Include the conversion note that product-specific IU-mcg relationships must be confirmed on the label.

IV obstetric effects on uterine tone can appear within minutes. Intranasal behavioral tasks are often timed 30-45 minutes after dosing in experimental protocols. SC analgesic endpoints in the 2024 trial were assessed in the post-injection experimental window defined by that study.

Plasma half-life after IV dosing is commonly summarized around 1-6 minutes (sometimes cited near 3-5 minutes), which is why infusions are used clinically. Intranasal and SC kinetics differ; central behavioral effects are not identical to plasma half-life.

Controlled research almost always isolates oxytocin when OXTR questions matter. Stacking with other neuroendocrine peptides muddies receptor-level inference. Clinical obstetric care follows dedicated protocols, not peptide stacks.

Convert vial mg to mcg (1 mg = 1,000 mcg), divide by diluent mL to get mcg/mL, then multiply by mL drawn. Because target experimental mcg amounts can be tiny, use adequate dilution and a precision syringe. Cross-check with a dosage calculator and a second person when preparing research aliquots.

Read the research yourself

These references were validated against the NCBI database. No citation appears here unless it resolves to a real paper.

Reference information only. The values below summarize amounts reported in published research literature and laboratory protocol discussions. They are not dosing recommendations, not medical advice, and not instructions for use in humans. All compounds referenced are for laboratory research use only and are not for human consumption.